Association of biological antirheumatic therapy with risk for type 2 diabetes: a retrospective cohort study in incident rheumatoid arthritis

OBJECTIVE: To explore possible associations of treatment with biological disease-modifying antirheumatic drugs (bDMARDs), including T-cell-based and interleukin-6 inhibition (IL-6i)-based therapies, and the risk for type 2 diabetes mellitus (T2DM) in patients with rheumatoid arthritis (RA). STUDY DE...

Descripción completa

Detalles Bibliográficos
Autores principales: Paul, Sanjoy K, Montvida, Olga, Best, Jennie H, Gale, Sara, Pethö-Schramm, Attila, Sarsour, Khaled
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Rheumatology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8211068/
https://www.ncbi.nlm.nih.gov/pubmed/34135030
http://dx.doi.org/10.1136/bmjopen-2020-042246

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8211068/
https://www.ncbi.nlm.nih.gov/pubmed/34135030
http://dx.doi.org/10.1136/bmjopen-2020-042246

Ejemplares similares